AU4549979A - Antibiotic mm13902 - Google Patents

Antibiotic mm13902

Info

Publication number
AU4549979A
AU4549979A AU45499/79A AU4549979A AU4549979A AU 4549979 A AU4549979 A AU 4549979A AU 45499/79 A AU45499/79 A AU 45499/79A AU 4549979 A AU4549979 A AU 4549979A AU 4549979 A AU4549979 A AU 4549979A
Authority
AU
Australia
Prior art keywords
antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU45499/79A
Other versions
AU530414B2 (en
Inventor
Dennis Butterworth
Martin Cole
John Dick Hood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB13856/74A priority Critical patent/GB1489235A/en
Priority to AT228475A priority patent/AT345454B/en
Priority to SE7503536*1A priority patent/SE7503536L/en
Priority to DE2513854A priority patent/DE2513854C2/en
Priority to AU79599/75A priority patent/AU499459B2/en
Priority to NL7503672A priority patent/NL7503672A/en
Priority to LU72155A priority patent/LU72155A1/xx
Priority to FR7509611A priority patent/FR2265399B1/fr
Priority to CH400175A priority patent/CH626628A5/en
Priority to CA223,313A priority patent/CA1050460A/en
Priority to JP50038464A priority patent/JPS582675B2/en
Priority to BE154898A priority patent/BE827332A/en
Priority to OA55487A priority patent/OA05204A/en
Priority to US05/717,334 priority patent/US4113856A/en
Priority to US05/725,383 priority patent/US4146610A/en
Priority to US05/725,384 priority patent/US4189473A/en
Priority to US05/858,101 priority patent/US4205067A/en
Priority to US05/942,457 priority patent/US4206202A/en
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Priority to AU45499/79A priority patent/AU530414B2/en
Publication of AU4549979A publication Critical patent/AU4549979A/en
Application granted granted Critical
Publication of AU530414B2 publication Critical patent/AU530414B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G11/00—Antibiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C12P17/184—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing a beta-lactam ring, e.g. thienamycin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU45499/79A 1974-03-28 1979-03-29 Antibiotic mm13902 Ceased AU530414B2 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GB13856/74A GB1489235A (en) 1974-03-28 1974-03-28 Antibiotics
AT228475A AT345454B (en) 1974-03-28 1975-03-25 Process for the preparation of a new, practically pure salt of an antibiotic
SE7503536*1A SE7503536L (en) 1974-03-28 1975-03-26 STREPTOMYCETAL ANTIBIOTICS.
NL7503672A NL7503672A (en) 1974-03-28 1975-03-27 PROCEDURE FOR PREPARING A NEW ANTIBIOTIC.
LU72155A LU72155A1 (en) 1974-03-28 1975-03-27
FR7509611A FR2265399B1 (en) 1974-03-28 1975-03-27
CH400175A CH626628A5 (en) 1974-03-28 1975-03-27 Process for the preparation of an antibiotic
CA223,313A CA1050460A (en) 1974-03-28 1975-03-27 Production of antibiotic mm 13902 by streptomyces
DE2513854A DE2513854C2 (en) 1974-03-28 1975-03-27 New antibiotics, processes for their preparation and pharmaceuticals containing these compounds
AU79599/75A AU499459B2 (en) 1974-03-28 1975-03-27 Antioboitics
JP50038464A JPS582675B2 (en) 1974-03-28 1975-03-28 Shinkikoseibutsu Shitsunoseihou
BE154898A BE827332A (en) 1974-03-28 1975-03-28 NEW ANTIBIOTIC FROM STREPTOMYCES
OA55487A OA05204A (en) 1974-03-28 1975-04-29 New antibiotics.
US05/717,334 US4113856A (en) 1974-03-28 1976-08-24 Antibiotic mm 13902
US05/725,384 US4189473A (en) 1974-03-28 1976-09-22 Antibiotic MM 13902
US05/725,383 US4146610A (en) 1974-03-28 1976-09-22 Antibiotics mm13902
US05/858,101 US4205067A (en) 1974-03-28 1977-12-07 Antibiotics
US05/942,457 US4206202A (en) 1974-03-28 1978-09-14 Antibiotics
AU45499/79A AU530414B2 (en) 1974-03-28 1979-03-29 Antibiotic mm13902

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB13856/74A GB1489235A (en) 1974-03-28 1974-03-28 Antibiotics
GB13856/74 1974-03-28
AU45499/79A AU530414B2 (en) 1974-03-28 1979-03-29 Antibiotic mm13902

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU79599/75A Division AU499459B2 (en) 1974-03-28 1975-03-27 Antioboitics

Publications (2)

Publication Number Publication Date
AU4549979A true AU4549979A (en) 1981-05-14
AU530414B2 AU530414B2 (en) 1983-07-14

Family

ID=25627229

Family Applications (2)

Application Number Title Priority Date Filing Date
AU79599/75A Ceased AU499459B2 (en) 1974-03-28 1975-03-27 Antioboitics
AU45499/79A Ceased AU530414B2 (en) 1974-03-28 1979-03-29 Antibiotic mm13902

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU79599/75A Ceased AU499459B2 (en) 1974-03-28 1975-03-27 Antioboitics

Country Status (13)

Country Link
JP (1) JPS582675B2 (en)
AT (1) AT345454B (en)
AU (2) AU499459B2 (en)
BE (1) BE827332A (en)
CA (1) CA1050460A (en)
CH (1) CH626628A5 (en)
DE (1) DE2513854C2 (en)
FR (1) FR2265399B1 (en)
GB (1) GB1489235A (en)
LU (1) LU72155A1 (en)
NL (1) NL7503672A (en)
OA (1) OA05204A (en)
SE (1) SE7503536L (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK145504C (en) * 1976-04-28 1983-04-25 Merck & Co Inc PROCEDURE FOR THE PREPARATION OF ANTIBIOTIC SUBSTANCE 890A2OG / OR ANTIBIOTIC SUBSTANCE 890A5 AND PHARMACEUTICAL ACCEPTABLE SALTS THEREOF
DK487877A (en) * 1976-11-17 1978-05-18 Merck & Co Inc PROCEDURE FOR THE PREPARATION OF AN ANTIBIOTIC SUBSTANCE
US4446146A (en) * 1978-07-26 1984-05-01 Beecham Group Limited β-Lactam containing compounds, their preparation and use
EP0008885B1 (en) * 1978-09-09 1983-11-30 Beecham Group Plc Beta-lactam compounds, their preparation and use
US4530791A (en) * 1979-04-16 1985-07-23 Kowa Co., Ltd. β-Lactam antibiotics
JPS6029668A (en) * 1983-07-28 1985-02-15 Hino Motors Ltd Economical driving guide device
US20080031955A1 (en) * 2004-06-30 2008-02-07 Rijkers Marinus Petrus Wilhelm Product Comprising a Beta-Lactam Antibiotic

Also Published As

Publication number Publication date
SE7503536L (en) 1975-09-29
CH626628A5 (en) 1981-11-30
FR2265399A1 (en) 1975-10-24
JPS50140692A (en) 1975-11-11
AU7959975A (en) 1976-09-30
BE827332A (en) 1975-09-29
NL7503672A (en) 1975-09-30
DE2513854C2 (en) 1984-04-19
JPS582675B2 (en) 1983-01-18
FR2265399B1 (en) 1978-08-04
OA05204A (en) 1981-02-28
LU72155A1 (en) 1975-08-20
AT345454B (en) 1978-09-25
DE2513854A1 (en) 1975-10-02
GB1489235A (en) 1977-10-19
ATA228475A (en) 1978-01-15
AU499459B2 (en) 1979-04-26
CA1050460A (en) 1979-03-13
AU530414B2 (en) 1983-07-14

Similar Documents

Publication Publication Date Title
AU497203B2 (en) Neohelometer
CA1016673A (en) Boronometer improvement
AU497283B2 (en) 1-thiadiazolimidazolidinones
AU467292B2 (en) Eye-bush
AU496973B2 (en) 5-nitro-imidazoles
AU530414B2 (en) Antibiotic mm13902
AU497101B2 (en) Antibiotic
AU490018B2 (en) Antibiotic substance
AU487412B2 (en) Antibiotic derivatives
AU491387B2 (en) Antibiotic a2041 derivatives
AU8503075A (en) Antibiotics
AU8518975A (en) Antibiotic compounds
AU8352575A (en) Antibiotic substance
AU518719B2 (en) Antibiotic mm 4550
AU8306075A (en) Antibiotic a2041 derivatives
AU496205B2 (en) Pyridylthioureas
AU489561B2 (en) Amidinoureas
AU482293B2 (en) 7-methoxycephalosporins
AU475114B2 (en) Arylalkylsulphoxides
AU468625B2 (en) Wire-connector
AU490236B2 (en) Daunomycins
AU493659B2 (en) 1-thiadiazolyl-6-acyloxyetrahydro-pyrimidinones
AU493202B2 (en) Spacer-turbulator
AU493093B2 (en) Pyridobenzodiazepinones
AU492269B2 (en) 14-desoxy-14-tosyloxyacetoxy-mutilin